Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy for Bell's Palsy
NCT03457025Phase 1Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Aug 2019
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in Bell's palsy (2 arms), sponsored by NYU Langone Health. Primary endpoint: Percentage of subjects that return to baseline facial function at 12 months. Planned start Aug 2019; status: withdrawn.
02
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT03457025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457025.